De‐Shen Wang

8.4k citations
132 papers · 6.6k · 4 hit papers · h-index 40

Impact in

    • Cancer-related molecular mechanisms research
  • Oncology top 1%
    • Inflammatory Biomarkers in Disease Prognosis
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Colorectal Cancer Treatments and Studies 22
    • Cancer Immunotherapy and Biomarkers 8
    • Drug Transport and Resistance Mechanisms 7
    • Pancreatic and Hepatic Oncology Research 5
    • Inflammatory Biomarkers in Disease Prognosis 5
    • Cancer, Lipids, and Metabolism 4

De‐Shen Wang

128 papers receiving 6.5k citations

De‐Shen Wang's Hit Papers

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial 2024 · 132 citations
1320+2+4Years since publication250500750

Peers

De‐Shen Wang
Comparison fields: 5 of 90
  • Cancer Research 896
  • Oncology 1.4k
  • Pulmonary and Respiratory Medicine 722
  • Molecular Biology 1.3k
  • Otorhinolaryngology 109
Replace Takatsugu Ishimoto with:
Takatsugu Ishimoto Japan
Peter Olson United States
M Volm Germany
Ying Jin China
Xiaoming Xie China
Zhao-Lei Zeng China
Masakazu Yashiro Japan
Paloma Cejas United States
Jonathan D. Tugwood United Kingdom
Yujuan Zhou China
De‐Shen Wang relative to Takatsugu Ishimoto Japan Takatsugu Ishimoto's profile →
Citations per field
00.5×1.5×
Takatsugu Ishimoto · 1×
Citations per year

Countries citing papers authored by De‐Shen Wang

Since Specialization
Citations

This map shows the geographic impact of De‐Shen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De‐Shen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De‐Shen Wang more than expected).

Fields of papers citing papers by De‐Shen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by De‐Shen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De‐Shen Wang. The network helps show where De‐Shen Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside De‐Shen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with De‐Shen Wang Line = papers co-authored together De‐Shen Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Circular RNA: metabolism, functions and interactions with proteins
Hit paper breakdown →
2020973
2
A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma
Hit paper breakdown →
2020428
3
LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer
Hit paper breakdown →
2019390
4 2016219
5 2012202
6 2018162
7 2020162
8 2018150
9 2015143
10 2013138
11
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
Hit paper breakdown →
2024132
12 2021127
13 2013124
14 2021121
15 2017118
16 2014115
17 2011108
18 2011105
19 201294
20 201890

About De‐Shen Wang

De‐Shen Wang is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Surgery, having authored 132 papers that have together received 6.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (22 papers), Gastric Cancer Management and Outcomes (13 papers), Cancer Immunotherapy and Biomarkers (8 papers), Drug Transport and Resistance Mechanisms (7 papers), Esophageal Cancer Research and Treatment (7 papers), Pancreatic and Hepatic Oncology Research (5 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (896 citations), Oncology (1.4k citations), Pulmonary and Respiratory Medicine (722 citations), Molecular Biology (1.3k citations) and Otorhinolaryngology (109 citations). De‐Shen Wang has collaborated with scholars based in China, United States and Mexico. Frequent co-authors include Rui‐Hua Xu, Huai‐Qiang Ju, Yu-hong Li, Miao‐Zhen Qiu, Zerong Cai, Jia Liu, Hui Luo, Dong-sheng Zhang, Zhao-Lei Zeng and Chao Ren. Their work appears in journals such as Cancer Medicine, Tumor Biology, Journal of Translational Medicine, Therapeutic Advances in Medical Oncology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact